You can contact Alloksys Life Sciences bv through the following persons
|
contact address office/labs
Alloksys / University Utrecht
JDV Building Yalelaan 104, 3584CM Utrecht
PO Box 80177, 3508TD Utrecht |
|
|
Paul Hamm
paul (at) alloksys.com
+ 32-(0) 897 30 111
+ 32-(0) 473 49 4397 |
|
|
Ruud Brands
ruud (at) alloksys.com
+31-(0)30-2533615
+31-(0)6-47228395 |
|
You may also fill in the contactform, we will react to your message as soon as possible
| 
Press releases
|
24 nov 2011: Hoopgevend onderzoek aan veelzijdig nieuw type geneesmiddel |
| Onderzoeksresultaten ondersteunen de theorie dat diverse aandoeningen
kunnen worden bestreden of voorkomen door toediening van bepaalde, van nature in het lichaam voorkomende, enzymen. Deze aandoeningen betreffen met name ontstekingsreacties en deze onde... |
| Read more.. |
|
Alloksys Life Sciences announces positive results with alkaline phosphatase in a phase IIa Clinical Trial in Patients undergoing CABG surgery with CPB. |
| Bunnik, The Netherlands, 23 April 2008 - Dutch biotechnology company Alloksys Life Sciences announces the successful completion of a phase IIa clinical trial (APPIRED) in patients undergoing bypass surgery with cardiopulmonary bypass... |
| Read more.. |
|
Drug development program started based on CAP Human Cell Line. New platform may provide solutions for many RA-patients around the world. |
| Alloksys Life Sciences BV (Bunnik, The Netherlands), CEVEC Pharmaceuticals GmbH (Cologne, Germany) and PharmaCell BV (Maastricht, The Netherlands) announce the start of Theraptech, a 2.4 million Euro therapeutic protein development program.... |
| Read more.. |
|
IBET joins ETB Theraptech project |
| IBET (Oeiras, Portugal) joins the Theraptech project. Theraptech aims to develop rec human ALP to be applied in arthritides diseases (e.g. RA and ankylosing spondylitis) as a preferred alternative to current TNFa blockers with a different MOA... |
| Read more.. |
|
New Experimental Medicine in EHEC |
| Bunnik, The Netherlands, June 7, 2011.
Dutch biopharmaceutical company Alloksys Life Sciences has an experimental medicine
which might help to counteract the effects of an EHEC infection.
"We now have over 10 years scientific research ....... |
| Read more.. |
|
Nieuw Experimenteel Medicijn in EHEC |
| Bunnik, 7 juni 2011.
Het Nederlandse biotechnologiebedrijf Alloksys Life Sciences heeft een experimenteel medicijn wat mogelijk kan helpen de gevolgen tegen te gaan van een EHEC-besmetting.
"We hebben inmiddels meer dan 10 jaar wetenschappelijk ....... |
| Read more.. |
|